The latest cancer drugs news
Browsing: Cancer Drug News
Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting
This content is password-protected. To view it, please enter the password below. Password:
New drug combination passes safety test in pancreatic cancer
A new study has shown a novel peptide antagonist, given in combination with a PD-1…
Cancer drug with better staying power, reduced toxicity promising in preclinical trial
A drug candidate has been found in preclinical trials to stop tumour growth entirely, deliver…
One drug, three action modes
H2020 European Research Council, Agence Nationale de la Recherche, Israel Science Foundation, Alex Grass Center…
FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma
The Food and Drug Administration (FDA) granted accelerated approval to the combination of nivolumab and…
Two-pronged attack on DNA repair could kill drug-resistant cancers
Launching a two-pronged attack on cancer’s ability to safeguard its DNA could offer an effective…
Experimental drug combination shows potential for triple-negative breast cancer
Researchers from Vanderbilt-Ingram Cancer Center, USA, discovered a role for MYCN in triple-negative breast cancer…
Starve a Tumour, Feed a Cell: How Cancers Can Resist Drugs
With drug resistance a major challenge in the fight against cancer, a discovery by University…
Scientists find cancer drug resistance genes and possibly how to limit their effects
St. Jude Children’s Research Hospital scientists have discovered a gene associated with about half of…
New drug combination could support better cancer treatments
Researchers have identified a promising new drug combination that could significantly help the immune system…